Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.11 -0.04 (-3.48%)
As of: Oct 23, 2026 · 2:58 PM EDT

Sonoma Pharmaceuticals (SNOA) EBITDA Margin (2010 - 2026)

Updated

Sonoma Pharmaceuticals' EBITDA Margin came in at -0.12% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 26.25 percentage points from -26.38% a year earlier and up 5.59 percentage points from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) EBITDA Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sonoma Pharmaceuticals reported EBITDA Margin of -5.80%, up 17.65 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -11.89%, up 13.11 percentage points from FY2025.

  • EBITDA Margin carries a five-year change of +5.41 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, EBITDA Margin was -25.00% in FY2025 (+10.53 pp), -35.53% in FY2024 (-2.04 pp), -33.49% in FY2023 (+11.65 pp) and -45.15% in FY2022 (-27.85 pp).
  • The fiscal Q1 2027 figure represents the highest quarterly EBITDA Margin since fiscal Q2 2021.
  • Year-over-year, EBITDA Margin has increased for six consecutive quarters, with an average year-over-year change of +14.41 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q4 2023 (a gain of 94.10 percentage points), and the weakest in fiscal Q3 2022 (a drop of 30.56 percentage points).
  • Business Quant data shows SNOA's EBITDA Margin at -5.72% (Q4 2026), -14.81% (Q3 2026) and -5.37% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.20 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 180.19 Bn 150.62 Bn 7.27 Bn 21.86%
3 Danaher 160.20 Bn 144.01 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 158.03 Bn 138.32 Bn 2.08 Bn 25.90%
5 Medtronic 122.78 Bn 88.04 Bn 6.34 Bn 25.55%
6 Stryker 118.35 Bn 104.47 Bn 4.50 Bn 29.67%
7 Boston Scientific 67.05 Bn 61.82 Bn 3.85 Bn 28.17%
8 Becton Dickinson 54.73 Bn 51.87 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 51.75 Bn 35.76 Bn 1.35 Bn 31.93%
10 Sonoma Pharmaceuticals 4.29 Mn -9.04 Mn 2.58 Mn -0.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.12%
Mar 31, 2026 -5.72%
Dec 31, 2025 -14.81%
Sep 30, 2025 -5.37%
Jun 30, 2025 -26.38%
Mar 31, 2025 -16.65%
Dec 31, 2024 -28.00%
Sep 30, 2024 -22.77%
Jun 30, 2024 -33.44%
Mar 31, 2024 -39.78%
Dec 31, 2023 -25.46%
Sep 30, 2023 -42.59%
Jun 30, 2023 -34.87%
Mar 31, 2023 -36.93%
Dec 31, 2022 -61.21%
Sep 30, 2022 -21.10%
Jun 30, 2022 -20.69%
Mar 31, 2022 -131.03%
Dec 31, 2021 -31.74%
Sep 30, 2021 -24.36%
API Access

Sonoma Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNOA&period=max&api_key=YOUR_API_KEY